Showing 1 - 20 results of 37 for search '"blindness"', query time: 0.09s Refine Results
  1. 1

    Study of peri-articular anaesthetic for replacement of the knee (SPAARK): study protocol for a patient-blinded, randomised controlled superiority trial of liposomal bupivacaine by Knight, R, Poulton, L, Strickland, L, Hamilton, T, Beard, D, Cook, J, Dutton, S, Leal, J, Lamb, S, Cooper, C, Barker, K, Murray, D, Pandit, H

    Published 2019
    “…</p> <p><strong>Methods:</strong> SPAARK is a patient-blinded, multi-centre, active comparator, superiority, two-arm, parallel-group, randomised controlled trial. …”
    Journal article
  2. 2
  3. 3

    Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome. by Perkins, G, Gates, S, Lamb, S, McCabe, C, Young, D, Gao, F

    Published 2011
    “…The Beta Agonist Lung Injury TrIal (BALTI-2) is a multicentre, pragmatic, randomised, double-blind, placebo-controlled clinical trial which aims to determine if sustained treatment with intravenous (IV) salbutamol will improve survival in ARDS. …”
    Journal article
  4. 4

    Platelet-rich plasma in Achilles tendon healing 2 (PATH-2) trial: statistical analysis plan for a multicentre, double-blinded, parallel-group, placebo-controlled randomised clinical trial by Schlüssel, M, Keene, D, Wagland, S, Alsousou, J, Lamb, S, Willett, K, Dutton, S

    Published 2018
    “…</p> <h4>Methods</h4> <p>PATH-2 is a pragmatic, parallel-group, multi-centre, double-blinded, randomised, placebo-controlled, superiority trial. …”
    Journal article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Randomised controlled trial of a behaviour change physiotherapy intervention to increase physical activity following hip and knee replacement: the PEP-TALK trial by Smith, TO, Parsons, S, Ooms, A, Dutton, S, Fordham, B, Garrett, A, Hing, C, Lamb, S

    Published 2022
    “…<br><br> <strong>Randomisation and blinding</strong> Initial 75 participants were randomised 1:1 before changing the allocation ratio to 2:1 (experimental:usual care). …”
    Journal article
  11. 11

    Exercise for people with a fragility fracture of the pelvis or lower limb: A systematic review of interventions evaluated in clinical trials and reporting quality by Keene, D, Forde, C, Sugavanam, T, Williams, M, Lamb, S

    Published 2020
    “…Trials would be improved by consistent blinded outcome assessor use and with consensus on which mobility outcomes should be assessed.…”
    Journal article
  12. 12

    Neuromuscular stimulation of the quadriceps muscle after hip fracture: a randomized controlled trial. by Lamb, S, Oldham, J, Morse, R, Evans, J

    Published 2002
    “… OBJECTIVE: To study the feasibility and effect of neuromuscular stimulation on recovery of mobility after surgical fixation for hip fracture. DESIGN: Double-blind study with stratified randomization. SETTING: Home-based rehabilitation program. …”
    Conference item
  13. 13

    Prehospital randomised assessment of a mechanical compression device in out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised trial and economic evaluation by Gates, S, Lall, R, Quinn, T, Deakin, C, Cooke, M, Horton, J, Lamb, S, Slowther, A, Woollard, M, Carson, A, Smyth, M, Wilson, K, Parcell, G, Rosser, A, Whitfield, R, Williams, A, Jones, R, Pocock, H, Brock, N, Black, J, Wright, J, Han, K, Shaw, G, Blair, L, Marti, J, Hulme, C, McCabe, C, Nikolova, S, Ferreira, Z, Perkins, G

    Published 2017
    “…Ambulance dispatch staff and those collecting the primary outcome were blind to treatment allocation. Blinding of the ambulance staff who delivered the interventions and reported initial response to treatment was not possible. …”
    Journal article
  14. 14

    The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol. by Perkins, G, Park, D, Alderson, D, Cooke, M, Gao, F, Gates, S, Lamb, S, Mistry, D, Thickett, DR

    Published 2011
    “…METHODS/DESIGN: The Beta Agonist Lung Injury TrIal (prevention) is a multi-centre, randomised, double blind, placebo-controlled trial. The aim of the trial is to determine in patients undergoing elective transthoracic oesphagectomy, if treatment with inhaled salmeterol 100 mcg twice daily started at induction of anaesthesia and continued for 72 hours thereafter compared to placebo affect the incidence of early acute lung injury and other clinical, resource and patient focused outcomes. …”
    Journal article
  15. 15

    A randomized controlled trial of exercise to improve mobility and function after elective knee arthroplasty. Feasibility, results and methodological difficulties. by Frost, H, Lamb, S, Robertson, S

    Published 2002
    “…OBJECTIVE: To assess the feasibility of comparing two types of exercise regime aiming to improve mobility and function following knee arthroplasty. DESIGN: A single-blind randomized controlled trial. SUBJECTS: Patients with primary, unilateral knee osteoarthritis undergoing elective knee joint replacement. …”
    Journal article
  16. 16

    Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture (PROVE): study protocol for a randomised controlled trial. by Barker, K, Javaid, M, Newman, M, Minns Lowe, C, Stallard, N, Campbell, H, Gandhi, V, Lamb, S

    Published 2014
    “…The trial is designed as a prospective, adaptive single-blinded randomised controlled trial. An interim analysis will be completed and if one intervention is clearly superior the trial will be adapted at this point to continue with just one intervention and the control. …”
    Journal article
  17. 17
  18. 18
  19. 19

    TIDieR-Placebo: a guide and checklist for reporting placebo and sham controls by Howick, J, Webster, RK, Rees, JL, Turner, R, Macdonald, H, Price, A, Evers, AWM, Bishop, F, Collins, GS, Bokelmann, K, Hopewell, S, Knottnerus, A, Lamb, S, Madigan, C, Napadow, V, Papanikitas, AN, Hoffmann, T

    Published 2020
    “…The main differences between TIDieR-Placebo and the original TIDieR are the explicit requirement to describe the setting (i.e., features of the physical environment that go beyond geographic location), the need to report whether blinding was successful (when this was measured), and the need to present the description of placebo components alongside those of the active comparator. …”
    Journal article
  20. 20